Cited by 171Diabetes Treatment and ManagementMetabolism, Diabetes, and CancerPancreatic function and diabetes

The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.

New hepatic targets for glycaemic control in diabetes

Open access

Agius, Loranne·2007·Best Practice & Research Clinical Endocrinology & Metabolism

DOI 10.1016/j.beem.2007.09.001

Open this paper in CoChat — free account

Abstract

Type-2 diabetes is associated with impaired glucose clearance by the liver in the postprandial state, and with elevated glucose production in the post-absorptive state. New targets within the liver are currently being investigated for development of antihyperglycaemic drugs for type-2 diabetes. They include glucokinase, which catalyses the first step in glucose metabolism, the glucagon receptor, and enzymes of gluconeogenesis and/or glycogenolysis such as glucose 6-phosphatase, fructose 1,6-bisphosphatase and glycogen phosphorylase. Preclinical studies with candidate drugs on animal models or cell-based assays suggest that these targets have the potential for pharmacological glycaemic control. Data from clinical studies is awaited. Further work is required for better understanding of the implications of targeting these sites in terms of possible side-effects or tachyphylaxis. The advantage of combined targeting of two or more sites within the liver for minimizing side-effects and tachyphylaxis caused by single-site targeting is discussed.

Integrity signals

Registry

Crossref · 10.1016/j.beem.2007.09.001

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice
Gelling, R. W., Du, X. Q., Dichmann, D. S., Rømer, J., Huang, H., Cui, L., Obici, S., Tang, B., Holst, J. J., Fledelius, C., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237106100 · Cited by 563
Allosteric Activators of Glucokinase: Potential Role in Diabetes Therapy
Grimsby, J. S., Sarabu, R., Corbett, W. L., Haynes, N.-E., Bizzarro, F. T., Coffey, J. W., Guertin, K. R., Hilliard, D. W., Kester, R. F., Mahaney, P. E., et al. (2003) · Science · doi:10.1126/science.1084073 · Cited by 526
Structural Basis for Allosteric Regulation of the Monomeric Allosteric Enzyme Human Glucokinase
Kamata, K., Mitsuya, M., Nishimura, T., Eiki, J., & Nagata, Y. (2004) · Structure · doi:10.1016/j.str.2004.02.005 · Cited by 502
Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo.
Cherrington, A. D. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1198 · Cited by 500
Specific features of glycogen metabolism in the liver
Bollen, M., Keppens, S., & Stalmans, W. (1998) · Biochemical Journal · doi:10.1042/bj3360019 · Cited by 409
The Family of Glycogen Phosphorylases: Structure and Functio
Newgard, C. B., Hwang, P. K., & Fletterick, R. J. (1989) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238909082552 · Cited by 392
The role of α-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications
Dunning, B. E., & Gerich, J. E. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0026 · Cited by 369
The Network of Glucokinase-Expressing Cells in Glucose Homeostasis and the Potential of Glucokinase Activators for Diabetes Therapy
Matschinsky, F. M., Magnuson, M. A., Zelent, D., Jetton, T. L., Doliba, N. M., Han, Y., Taub, R. A., & Grimsby, J. S. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0926 · Cited by 302
Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange
DeFronzo, R. A., Ferrannini, E., Hendler, R., Wahren, J., & Felig, P. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.5173 · Cited by 296
Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus
Treadway, J. L., Mendys, P., & Hoover, D. J. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.3.439 · Cited by 260
Taxonomy, Fermentation, Isolation and Biological Activities.
Mori, H., Urano, Y., Abe, F., Furukawa, S., Furukawa, S., TSURUMI, Y., Sakamoto, K., Hashimoto, M., Takase, S., Hino, M., et al. (2003) · The Journal of Antibiotics · doi:10.7164/antibiotics.56.72 · Cited by 238
Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo
Martin, W. H., Hoover, D. J., Armento, S. J., Stock, I. A., McPherson, R. K., Danley, D. E., Stevenson, R. W., Barrett, E. J., & Treadway, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1776 · Cited by 232
Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans
Petersen, K. F., & Sullivan, J. T. (2001) · Diabetologia · doi:10.1007/s001250100006 · Cited by 209
Reduction in Glucagon Receptor Expression by an Antisense Oligonucleotide Ameliorates Diabetic Syndrome in db/db Mice
Liang, Y. T., Osborne, M. C., Monia, B. P., Bhanot, S., Gaarde, W. A., Reed, C. A., She, P., Jetton, T. L., & Demarest, K. T. (2004) · Diabetes · doi:10.2337/diabetes.53.2.410 · Cited by 202
Perturbation of Fuel Homeostasis Caused by Overexpression of the Glucose-6-phosphatase Catalytic Subunit in Liver of Normal Rats
Trinh, K. Y., O'Doherty, R. M., Anderson, P., Lange, A. J., & Newgard, C. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31615 · Cited by 191
Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia.
O'Doherty, R. M., Lehman, D. L., Télémaque, S., & Newgard, C. B. (1999) · Diabetes · doi:10.2337/diabetes.48.10.2022 · Cited by 187
Glucose Regulates in Vivo Glucose-6-phosphatase Gene Expression in the Liver of Diabetic Rats
Massillon, D., Barzilai, N., Chen, W., Hu, M., & Rossetti, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9871 · Cited by 168
Glycogen Phosphorylase as a Molecular Target for Type 2 Diabetes Therapy
Oikonomakos, N. G. (2002) · Current Protein and Peptide Science · doi:10.2174/1389203023380422 · Cited by 166
MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes
Erion, M. D., van Poelje, P. D., Dang, Q., Kasibhatla, S. R., Potter, S. C., Reddy, M. R., Reddy, K. R., Jiang, T., & Lipscomb, W. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502983102 · Cited by 162
Glycemic Control in Mice with Targeted Disruption of the Glucagon Receptor Gene
Parker, J. C., Andrews, K. M., Allen, M. R., Stock, J. L., & McNeish, J. D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6265 · Cited by 160
Evidence for a Role of Glucose-induced Translocation of Glucokinase in the Control of Hepatic Glycogen Synthesis
Agius, L., Peak, M., Newgard, C. B., Gómez-Foix, A. M., & Guinovart, J. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30479 · Cited by 150
Self-citation
Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes.
Clore, J. N., Stillman, J., & Sugerman, H. J. (2000) · Diabetes · doi:10.2337/diabetes.49.6.969 · Cited by 146
Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.
Mevorach, M., Giacca, A., Aharon, Y., Hawkins, M. A., Shamoon, H., & Rossetti, L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2720 · Cited by 143
Liver Glucokinase: Decreased Activity in Patients with Type II Diabetes
Caro, J., Triester, S. L., Patel, V., Tapscott, E. B., Leggett-Frazier, N., & Dohm, G. L. (1995) · Hormone and Metabolic Research · doi:10.1055/s-2007-979899 · Cited by 135
A new allosteric site in glycogen phosphorylase b as a target for drug interactions
Oikonomakos, N. G., Skamnaki, V. T., Tsitsanou, K. E., Gavalas, N. G., & Johnson, L. N. (2000) · Structure · doi:10.1016/s0969-2126(00)00144-1 · Cited by 132
A Novel Glucokinase Activator Modulates Pancreatic Islet and Hepatocyte Function
Efanov, A. M., Barrett, D. G., Brenner, M. B., Briggs, S., Delaunois, A. G., Durbin, J. D., Giese, U., Guo, H., Radloff, M., Gil, G. S., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0377 · Cited by 131
Stimulation of Hepatocyte Glucose Metabolism by Novel Small Molecule Glucokinase Activators
Brocklehurst, K. J., Payne, V. A., Davies, R. A., Carroll, D., Vertigan, H. L., Wightman, H. J., Aiston, S., Waddell, I. D., Leighton, B., Coghlan, M. P., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.3.535 · Cited by 130
Self-citation
Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus
Wajngot, A., Chandramouli, V., Schumann, W. C., Ekberg, K., Jones, P. K., Efendic, S., & Landau, B. R. (2001) · Metabolism · doi:10.1053/meta.2001.19422 · Cited by 128
Small Increases in Insulin Inhibit Hepatic Glucose Production Solely Caused by an Effect on Glycogen Metabolism
Edgerton, D. S., Cardin, S., Emshwiller, M., Neal, D. W., Chandramouli, V., Schumann, W. C., Landau, B. R., Rossetti, L., & Cherrington, A. D. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1872 · Cited by 127
Human liver glycogen phosphorylase inhibitors bind at a new allosteric site
Rath, V. L., Ammirati, M. J., Danley, D. E., Ekstrom, J. L., Gibbs, E. M., Hynes, T. R., Mathiowetz, A. M., McPherson, R. K., Olson, T. V., Treadway, J. L., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00004-1 · Cited by 126
Flavopiridol Inhibits Glycogen Phosphorylase by Binding at the Inhibitor Site
Oikonomakos, N. G., Schnier, J. B., Zographos, S. E., Skamnaki, V. T., Tsitsanou, K. E., & Johnson, L. N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004485200 · Cited by 124
Inhibition of glycogenolysis in primary rat hepatocytes by 1,4-dideoxy-1,4-imino-D-arabinitol
ANDERSEN, B., RASSOV, A., Westergaard, N., & Lundgren, K. (1999) · Biochemical Journal · doi:10.1042/bj3420545 · Cited by 115
Glycogen Phosphorylase Inhibitors
Henke, B. R., & Sparks, S. M. (2006) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955706777934991 · Cited by 114
Pentacyclic triterpenes. Part 1: The first examples of naturally occurring pentacyclic triterpenes as a new class of inhibitors of glycogen phosphorylases
Wen, X., Sun, H., Liu, J., Wu, G., Zhang, L., Wu, X., & Ni, P. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.08.026 · Cited by 112
Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance
Ferré, T., Riu, E., Franckhauser, S., Agudo, J., & Bosch, F. (2003) · Diabetologia · doi:10.1007/s00125-003-1244-z · Cited by 109
A Novel Glucagon Receptor Antagonist Inhibits Glucagon-Mediated Biological Effects
Qureshi, S. A., Candelore, M. R., Xie, D., Yang, X., Tota, L. M., Ding, V. D. H., Li, Z., Bansal, A., Miller, C. O., Cohen, S. M., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3267 · Cited by 109
Activation of Human Liver Glycogen Phosphorylase by Alteration of the Secondary Structure and Packing of the Catalytic Core
Rath, V. L., Ammirati, M., LeMotte, P. K., Fennell, K. F., Mansour, M. N., Danley, D. E., Hynes, T. R., Schulte, G. K., Wasilko, D. J., & Pandit, J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00006-7 · Cited by 107
Expression of Human Hepatic Glucokinase in Transgenic Mice Liver Results in Decreased Glucose Levels and Reduced Body Weight
Hariharan, N., Farrelly, D., Hagan, D. L., Hillyer, D. E., ARBEENY, C. M., Sabrah, T., Treloar, A., Brown, K. S., Kalinowski, S. S., & Mookhtiar, K. A. (1997) · Diabetes · doi:10.2337/diab.46.1.11 · Cited by 107
Indole-2-carboxamide Inhibitors of Human Liver Glycogen Phosphorylase
Hoover, D. J., Snow, S. L., Burgess‐Henry, J., Martin, W. H., Armento, S. J., Stock, I. A., McPherson, R. K., Genereux, P. E., Gibbs, E. M., & Treadway, J. L. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980264k · Cited by 100
An Allosteric Activator of Glucokinase Impairs the Interaction of Glucokinase and Glucokinase Regulatory Protein and Regulates Glucose Metabolism
Futamura, M., Hosaka, H., Kadotani, A., Shimazaki, H., Sasaki, K., Ohyama, S., Nishimura, T., Eiki, J., & Nagata, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605186200 · Cited by 100
Pharmacological Approaches to Inhibit Endogenous Glucose Production as a Means of Anti-diabetic Therapy
McCormack, J., Westergaard, N., Kristiansen, M., Brand, C. L., & Lau, J. F. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397393 · Cited by 97
Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes
Basu, R., Basu, A., Johnson, C. M., Schwenk, W. F., & Rizza, R. A. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2042 · Cited by 97
Hypoglycaemic effect of AICAriboside in mice
Vincent, M. F., Erion, M. D., Gruber, H. E., & den Berghe, G. V. (1996) · Diabetologia · doi:10.1007/bf02658500 · Cited by 93
Kinetic and Functional Characterization of 1,4-Dideoxy-1,4-imino--arabinitol: A Potent Inhibitor of Glycogen Phosphorylase with Anti-hyperglyceamic Effect in ob/ob Mice
Fosgerau, K., Westergaard, N., Quistorff, B., Grunnet, N., Kristiansen, M., & Lundgren, K. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1930 · Cited by 91
Glucokinase and glucose homeostasis: proven concepts and new ideas
Zelent, D., Najafi, H., Odili, S., Buettger, C. W., Weik-Collins, H., Li, Z., Doliba, N. M., Grimsby, J. S., & Matschinsky, F. M. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330306 · Cited by 90
Acute Inhibition of Hepatic Glucose-6-phosphatase Does Not Affect Gluconeogenesis but Directs Gluconeogenic Flux toward Glycogen in Fasted Rats
Dijk, V. T., van der Sluijs, Wiegman, C., Baller, J. F. W., GUSTAFSON, L. A., Burger, H.-J., Herling, A., Kuipers, F., Meijer, A. J., & Reijngoud, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101223200 · Cited by 90
Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions
Fyfe, M. C. T., White, J. R., Taylor, A., Chatfield, R., Wargent, E. T., Printz, R. L., Sulpice, T., McCormack, J. G., Procter, M. J., Reynet, C., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0646-8 · Cited by 87
Inhibition of Fructose 1,6-Bisphosphatase Reduces Excessive Endogenous Glucose Production and Attenuates Hyperglycemia in Zucker Diabetic Fatty Rats
van Poelje, P. D., Potter, S. C., Chandramouli, V. C., Landau, B. R., Dang, Q., & Erion, M. D. (2006) · Diabetes · doi:10.2337/db05-1443 · Cited by 87
Iminosugars: potential inhibitors of liver glycogen phosphorylase
Jakobsen, P., Lundbeck, J. M., Kristiansen, M., Breinholt, J., Demuth, H., Pawlas, J., Candela, M. P. T., Andersen, B., Westergaard, N., Lundgren, K., et al. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00291-1 · Cited by 85
Anilinoquinazoline Inhibitors of Fructose 1,6-Bisphosphatase Bind at a Novel Allosteric Site: Synthesis, In Vitro Characterization, and X-ray Crystallography
Wright, S. W., Carlo, A. A., Carty, M. D., Danley, D. E., Hageman, D. L., Karam, G. A., Levy, C. B., Mansour, M. N., Mathiowetz, A. M., McClure, L. D., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010496a · Cited by 83
Immunoneutralization of Endogenous Glucagon Reduces Hepatic Glucose Output and Improves Long-Term Glycemic Control in Diabetic ob/ob Mice
Sørensen, H., Brand, C. L., Neschen, S., Holst, J. J., Fosgerau, K., Nishimura, E., & Shulman, G. I. (2006) · Diabetes · doi:10.2337/db06-0222 · Cited by 80
Glucose-6-phosphatase Overexpression Lowers Glucose 6-Phosphate and Inhibits Glycogen Synthesis and Glycolysis in Hepatocytes without Affecting Glucokinase Translocation
Aiston, S., Trinh, K. Y., Lange, A. J., Newgard, C. B., & Agius, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24559 · Cited by 79
Self-citation
Acyl Ureas as Human Liver Glycogen Phosphorylase Inhibitors for the Treatment of Type 2 Diabetes
Klabunde, T., Wendt, K. U., Kadereit, D., Brachvogel, V., Burger, H.-J., Herling, A. W., Oikonomakos, N. G., Kosmopoulou, M. N., Schmoll, D., Sarubbi, E., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049034y · Cited by 77
Hepatic Glycogen Synthesis Is Highly Sensitive to Phosphorylase Activity
Aiston, S., Hampson, L. J., Gómez-Foix, A. M., Guinovart, J. J., & Agius, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101454200 · Cited by 74
Self-citation
Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats
Coope, G., Atkinson, A. M., Allott, C. P., McKerrecher, D., Johnstone, C., Pike, K. G., Holme, P. C., Vertigan, H. L., Gill, D., Coghlan, M. P., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706848 · Cited by 73
Small Molecule Glucokinase Activators as Glucose Lowering Agents: A New Paradigm for Diabetes Therapy
Guertin, K. R., & Grimsby, J. S. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777452551 · Cited by 72
Acute Inhibition of Glucose-6-Phosphate Translocator Activity Leads to Increased De Novo Lipogenesis and Development of Hepatic Steatosis Without Affecting VLDL Production in Rats
Bandsma, R., Wiegman, C., Herling, A. W., Burger, H.-J., ter Harmsel, A., Meijer, A. J., Romijn, J. A., Reijngoud, D., & Kuipers, F. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2591 · Cited by 70
The physiological role of glucokinase binding and translocation in hepatocytes
Agius, L. (1998) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(97)00001-0 · Cited by 67
Self-citation
Iminosugars as Potential Inhibitors of Glycogenolysis: Structural Insights into the Molecular Basis of Glycogen Phosphorylase Inhibition
Oikonomakos, N. G., Tiraidis, C., Leonidas, D. D., Zographos, S. E., Kristiansen, M., Jessen, C. U., Nørskov‐Lauritsen, L., & Agius, L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060496g · Cited by 65
Self-citation
Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes.
Parker, J. C., McPherson, R. K., Andrews, K. M., Levy, C. B., Dubins, J. S., Chin, J. E., Perry, P., Hulin, B., Perry, D. A., Inagaki, T., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2079 · Cited by 65
Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors
Ogawa, A. K., Willoughby, C. A., Bergeron, R., Ellsworth, K. P., Geissler, W. M., Myers, R. W., Yao, J., Harris, G., & Chapman, K. T. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00798-4 · Cited by 65
Inactivation of phosphorylase is a major component of the mechanism by which insulin stimulates hepatic glycogen synthesis
Aiston, S., Coghlan, M. P., & Agius, L. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03648.x · Cited by 62
Self-citation
Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats
Herling, A. W., Burger, H.-J., Schubert, G., Hemmerle, H., Schaefer, H.-L., & Kramer, W. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00748-7 · Cited by 62
Dual Role of Phosphofructokinase-2/Fructose Bisphosphatase-2 in Regulating the Compartmentation and Expression of Glucokinase in Hepatocytes
Payne, V. A., Arden, C., Wu, C., Lange, A. J., & Agius, L. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1949 · Cited by 60
Self-citation
Natural flavonoids are potent inhibitors of glycogen phosphorylase
Jakobs, S., Fridrich, D., Hofem, S., Pahlke, G., & Eisenbrand, G. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500163 · Cited by 60
Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
Parker, J. C., VanVolkenburg, M. A., Levy, C. B., Martin, W. H., Burk, S. H., Kwon, Y., Giragossian, C., Gant, T. G., Carpino, P. A., McPherson, R. K., et al. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1630 · Cited by 58
The Cyclin-Dependent Kinase (CDK) Inhibitor Flavopiridol Inhibits Glycogen Phosphorylase
Kaiser, A., Nishi, K., Gorin, F. A., Walsh, D. A., Bradbury, E. M., & Schnier, J. B. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2220 · Cited by 57
Discovery, synthesis and biological evaluation of novel glucokinase activators
McKerrecher, D., Allen, J. V., Bowker, S. S., Boyd, S., Caulkett, P. W. R., Currie, G. S., Davies, C. D., Fenwick, M. L., Gaskin, H., Grange, E., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.01.087 · Cited by 55
Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism
Brichard, S. M., Henquin, J., & Girard, J. R. (1993) · Diabetologia · doi:10.1007/bf00400230 · Cited by 54
Hepatic Enzyme Activities of Glycolysis and Gluconeogenesis in Diabetes of Man and Laboratory Animals
Willms, B., Ben-Ami, P., & Söling, H. (1970) · Hormone and Metabolic Research · doi:10.1055/s-0028-1095102 · Cited by 53
Glucose regulation of gene expression
Foufelle, F., Girard, J. R., & Ferré, P. (1998) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-199807000-00002 · Cited by 53
Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes
LATSIS, T., ANDERSEN, B., & Agius, L. (2002) · Biochemical Journal · doi:10.1042/bj20021070 · Cited by 52
Self-citation
Structure-Activity Analysis of the Purine Binding Site of Human Liver Glycogen Phosphorylase
Ekstrom, J. L., Pauly, T. A., Carty, M. D., Soeller, W. C., Culp, J., Danley, D. E., Hoover, D. J., Treadway, J. L., Gibbs, E. M., Fletterick, R. J., et al. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00186-2 · Cited by 50
3-(2-Carboxy-ethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site
Wright, S. W., Carlo, A. A., Danley, D. E., Hageman, D. L., Karam, G. A., Mansour, M. N., McClure, L. D., Pandit, J., Schulte, G. K., Treadway, J. L., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00310-x · Cited by 50
Molecular mode of inhibition of glycogenolysis in rat liver by the dihydropyridine derivative, BAY R3401: inhibition and inactivation of glycogen phosphorylase by an activated metabolite.
Bergans, N., Stalmans, W., Goldmann, S., & Vanstapel, F. J. L. A. (2000) · Diabetes · doi:10.2337/diabetes.49.9.1419 · Cited by 49
Dual-acting peptide with prolonged glucagon-like peptide-1 receptor agonist and glucagon receptor antagonist activity for the treatment of type 2 diabetes
Claus, T. H., Pan, C. Q., Buxton, J. M., Yang, L., Reynolds, J. C., Barucci, N., Burns, M. G., Ortiz, A. A., Roczniak, S., Livingston, J. N., et al. (2007) · Journal of Endocrinology · doi:10.1677/joe-06-0018 · Cited by 46
Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3‐isopropyl 4‐(2‐chlorophenyl)‐1,4‐dihydro‐1‐ethyl‐2‐methyl‐pyridine‐3,5,6‐tricarboxylate
Oikonomakos, N. G., Tsitsanou, K. E., Zographos, S. E., Skamnaki, V. T., Goldmann, S., & Bischoff, H. (1999) · Protein Science · doi:10.1110/ps.8.10.1930 · Cited by 43
Glucokinase-activating ureas
Castelhano, A. L., Dong, H., Fyfe, M. C. T., Gardner, L. S., Kamikozawa, Y., Kurabayashi, S., Nawano, M., Ohashi, R., Procter, M. J., Li, Q., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.083 · Cited by 43
A Novel Glucagon Receptor Antagonist, NNC 25-0926, Blunts Hepatic Glucose Production in the Conscious Dog
Rivera, N., Grueter, C. A., Edgerton, D. S., Rodewald, T., Neal, D. W., Nishimura, E., Larsen, M. O., Jacobsen, L. O., Kristensen, K., Brand, C. L., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.115717 · Cited by 43
Inhibition of Fructose-1,6-bisphosphatase by a New Class of Allosteric Effectors
Choe, J.-Y., Nelson, S. W., Arienti, K. L., Axe, F. U., Collins, T. L., Jones, T. K., Kimmich, R. D. A., Newman, M. J., Norvell, K., Ripka, W. C., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308396200 · Cited by 41
Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitors
Birch, A. M., Kenny, P. W., Oikonomakos, N. G., Otterbein, L. R., Schofield, P. N., Whittamore, P. R. O., & Whalley, D. P. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.10.037 · Cited by 40
Identification, Synthesis, and Characterization of New Glycogen Phosphorylase Inhibitors Binding to the Allosteric AMP Site
Kristiansen, M., Andersen, B., Iversen, L. F., & Westergaard, N. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031121n · Cited by 40
Glucose 6-phosphate causes translocation of phosphorylase in hepatocytes and inactivates the enzyme synergistically with glucose
Aiston, S., GREEN, A., Mukhtar, M. H., & Agius, L. (2004) · Biochemical Journal · doi:10.1042/bj20031191 · Cited by 39
Self-citation
Quantitation of glycogen synthase and phosphorylase protein in mouse liver: Correlation between enzymatic protein and enzyme activity
Roesler, W. J., & Khandelwal, R. L. (1986) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(86)90130-x · Cited by 35
Novel 3,4-Dihydroquinolin-2(1 H )-one inhibitors of human glycogen phosphorylase a
Rosauer, K. G., Ogawa, A. K., Willoughby, C. A., Ellsworth, K. P., Geissler, W. M., Myers, R. W., Deng, Q., Chapman, K. T., Harris, G., & Moller, D. E. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.022 · Cited by 35
A new class of glycogen phosphorylase inhibitors
Lu, Z., Bohn, J., Bergeron, R., Deng, Q., Ellsworth, K. P., Geissler, W. M., Harris, G., McCann, P. E., McKeever, B. M., Myers, R. W., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.046 · Cited by 35
The role of glucose 6‐phosphate in mediating the effects of glucokinase overexpression on hepatic glucose metabolism
Härndahl, L., Schmoll, D., Herling, A. W., & Agius, L. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.05067.x · Cited by 33
Self-citation
The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors
Andersen, B. B., & Westergaard, N. (2002) · Biochemical Journal · doi:10.1042/bj20020153 · Cited by 33
Effects of C-1-substituted glucose analogue on the activation states of glycogen synthase and glycogen phosphorylase in rat hepatocytes
M Board, Bollen, M., Stalmans, W., Kim, Y., Fleet, G. W. J., & Johnson, L. N. (1995) · Biochemical Journal · doi:10.1042/bj3110845 · Cited by 31
Effects of Novel Analogues of D-Glucose on Glycogen Phosphorylase Activities in Crude Extracts of Liver and Skeletal Muscle
Mary Board, Hadwen, M., & Johnson, L. N. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0753m.x · Cited by 30
Novel thienopyrrole glycogen phosphorylase inhibitors: Synthesis, in vitro SAR and crystallographic studies
Whittamore, P. R. O., Addie, M. S., Bennett, S. N. L., Birch, A. M., Butters, M., Godfrey, L., Kenny, P. W., Morley, A., Murray, P. M., Oikonomakos, N. G., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.08.047 · Cited by 30
The Experimental Type 2 Diabetes Therapy Glycogen Phosphorylase Inhibition Can Impair Aerobic Muscle Function During Prolonged Contraction
Baker, D. J., Greenhaff, P. L., MacInnes, A., & Timmons, J. A. (2006) · Diabetes · doi:10.2337/db05-1687 · Cited by 30
Expression of human hepatic glucokinase in transgenic mice liver results in decreased glucose levels and reduced body weight
Hariharan, N., Farrelly, D., Hagan, D., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.1.11 · Cited by 30
Discovery and Actions of Glucokinase Activators
Grimsby, J. S., Matschinsky, F. M., & Grippo, J. F. (2004) · KARGER eBooks · doi:10.1159/000079030 · Cited by 29
Bioactivity of glycogen phosphorylase inhibitors that bind to the purine nucleoside site
Hampson, L. J., Arden, C., Agius, L., Ganotidis, M., Kosmopoulou, M. N., Tiraidis, C., Elemes, Y., Sakarellos, C., Leonidas, D. D., & Oikonomakos, N. G. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.07.060 · Cited by 27
Self-citation
Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme
Freeman, S., Bartlett, J. B., Convey, G., Hardern, I. M., Teague, J., Loxham, S. J. G., Allen, J. M., Poucher, S. M., & Charles, A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706925 · Cited by 27
Peroxyvanadium Compounds Inhibit Glucose-6-phosphatase Activity and Glucagon-Stimulated Hepatic Glucose Output in the Ratin Vivo
Westergaard, N., Brand, C. L., Lewinsky, R., Andersen, H. S., Carr, R. D., Burchell, A. N., & Lundgren, K. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1181 · Cited by 26
Impaired glycogen synthesis in hepatocytes from Zucker fatty fa/fa rats: the role of increased phosphorylase activity
Aiston, S., Peak, M., & Agius, L. (2000) · Diabetologia · doi:10.1007/s001250051348 · Cited by 25
Self-citation
Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs
Oikonomakos, N. G., Kosmopoulou, M. N., Chrysina, E. D., Leonidas, D. D., Kostas, I. D., Wendt, K. U., Klabunde, T., & Defoßa, E. (2005) · Protein Science · doi:10.1110/ps.051432405 · Cited by 25
Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs
Shiota, M., Jackson, P. A., Bischoff, H., McCaleb, M. L., Scott, M. F., Monohan, M., Neal, D. W., & Cherrington, A. D. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.5.e868 · Cited by 24
FR258900, a Novel Glycogen Phosphorylase Inhibitor Isolated from Fungus No. 138354
Furukawa, S., Murakami, K., NISHIKAWA, M., Nakayama, O., & Hino, M. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.67 · Cited by 20
Evidence against Glycogen Cycling of Gluconeogenic Substrates in Various Liver Preparations
Fosgerau, K., Breinholt, J., McCormack, J. G., & Westergaard, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201565200 · Cited by 17
Increased Potency and Efficacy of Combined Phosphorylase Inactivation and Glucokinase Activation in Control of Hepatocyte Glycogen Metabolism
Hampson, L. J., & Agius, L. (2005) · Diabetes · doi:10.2337/diabetes.54.3.617 · Cited by 14
Self-citation
FR258900, a Novel Glycogen Phosphorylase Inhibitor Isolated from Fungus No. 138354
Furukawa, S., TSURUMI, Y., Murakami, K., Nakanishi, T., Ohsumi, K., Hashimoto, M., NISHIKAWA, M., Takase, S., Nakayama, O., & Hino, M. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.66 · Cited by 12
FR258900, a potential anti‐hyperglycemic drug, binds at the allosteric site of glycogen phosphorylase
Tiraidis, C., Alexacou, K.-M., Zographos, S. E., Leonidas, D. D., Gimisis, T., & Oikonomakos, N. G. (2007) · Protein Science · doi:10.1110/ps.072925607 · Cited by 11
GKRP/GK: Control of Metabolic Fluxes in Hepatocytes
Agius, L., Aiston, S., Mukhtar, M. H., & de la Iglesia, N. (2004) · KARGER eBooks · doi:10.1159/000079018 · Cited by 9
Self-citation
Identification of two novel and potent competitive inhibitors of the glucose‐6‐phosphatase catalytic protein
Westergaard, N., Madsen, P., Lundbeck, J. M., Jakobsen, P., Varming, A. R., & Andersen, B. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00179.x · Cited by 9
Hepatic glucokinase activity in human diabetics and nondiabetics
Ferris, S. A. (1964) · Metabolism · doi:10.1016/0026-0495(64)90042-3 · Cited by 7

Sorted by citations

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Management of type 2 diabetes: new and future developments in treatment
Tahrani, A. A., Bailey, C. J., Prato, S. D., & Barnett, A. H. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60207-9 · Cited by 541
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
Åhrén, B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2782 · Cited by 422
Glucokinase and molecular aspects of liver glycogen metabolism
Agius, L. (2008) · Biochemical Journal · doi:10.1042/bj20080595 · Cited by 407
Self-citation
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
Rines, A. K., Sharabi, K., Tavares, C. D. J., & Puigserver, P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.151 · Cited by 390

See all 171

Authors: Agius, L.
Affiliations: Newcastle University (GB)
Corresponding author: Agius, Loranne
ORCID: Agius, Loranne
Venue: Best Practice & Research Clinical Endocrinology & Metabolism
Publisher: Elsevier BV
Published: 2007-12
Volume: 21
Issue: 4
Pages: 587-605
ISSN: 1521-690X (ISSN-L)
DOI: 10.1016/j.beem.2007.09.001
OpenAlex: W2132179056
Cited by: 155
References: 107
Citations by year: 2026: 3 · 2025: 5 · 2024: 5 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 11 · 2019: 2 · 2018: 10 · 2017: 10 · 2016: 10 · 2015: 13 · 2014: 10 · 2013: 12 · 2012: 16
FWCI: 1.91
Type: journal article
Language: en
Open access: green
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Best Practice & Research Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Newcastle University ePrints (Newcastle Univesity)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords: type 2 diabetes, hepatic glucose metabolism, antidiabetic drugs, glucokinase, glucagon receptor, gluconeogenesis, glycogenolysis, glucose-6-phosphatase, fructose-1,6-bisphosphatase, glycogen phosphorylase, tachyphylaxis, adverse drug reactions
MeSH terms: Animals, Binding Sites, Blood Glucose, Diabetes Mellitus, Type 2, Enzyme Inhibitors, Glucagon, Glucokinase, Gluconeogenesis, Glucose-6-Phosphatase, Fructose-Bisphosphatase, Humans, Hypoglycemic Agents, Liver, Glycogen Phosphorylase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

New hepatic targets for glycaemic control in diabetes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks